2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
27
Neoplasms
20
Cancer Pain
10
Colonic Neoplasms
7
Breakthrough Pain
7
Agnosia
7
Breast Neoplasms
5
Rectal Neoplasms
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Chronic Pain
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Pain, Postoperative
3
Lymphoma, Follicular
3
Breakthrough Cancer Pain
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Pleural Effusion, Malignant
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Interventions
Dexamethasone
5
ramosetron
3
Ondansetron
2
Calcium Dobesilate
2
Acupuncture Therapy
2
phenazine
1
esmolol
1
Therapeutics
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Olanzapine
1
Gelatin
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Aprepitant
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Analgesics, Opioid
1
Adrenergic beta-Antagonists
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Postoperative Nausea and Vomiting
×
Fentanyl
×
Clear all
NCT01544959
2018-10-24
PAINFree
Université de Sherbrooke
Phase NA
Completed
84 enrolled